Grifols SA (GRFS)
Grifols Market Cap: 6.131B for Jan. 21, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Biodexa Pharmaceuticals Plc | 1.774M |
| DBV Technologies SA | 593.75M |
| Autolus Therapeutics Plc | 392.56M |
| Mereo BioPharma Group Plc | 86.66M |
| Evaxion AS | 26.28M |
Market Cap Related Metrics
| PE Ratio | 14.67 |
| PS Ratio | 0.7372 |
| PEG Ratio | 0.0883 |
| Price to Book Value | 2.660 |
| Price to Free Cash Flow | 7.909 |
| Price | 9.01 |
| Earnings Yield | 6.82% |
| PEGY Ratio | 0.0873 |
| Operating PE Ratio | 4.076 |
| Normalized PE Ratio | 15.43 |